The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(Z)-6-(3-fluorophenyl)-2-methyl-N'-(1-methyl-2-oxoindolin-3-ylidene)nicotinohydrazide ID: ALA3806315
PubChem CID: 137225057
Max Phase: Preclinical
Molecular Formula: C22H17FN4O2
Molecular Weight: 388.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1nc(-c2cccc(F)c2)ccc1C(=O)N/N=C1\C(=O)N(C)c2ccccc21
Standard InChI: InChI=1S/C22H17FN4O2/c1-13-16(10-11-18(24-13)14-6-5-7-15(23)12-14)21(28)26-25-20-17-8-3-4-9-19(17)27(2)22(20)29/h3-12H,1-2H3,(H,26,28)/b25-20-
Standard InChI Key: GKQGJHOWGSJVSZ-QQTULTPQSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
4.1182 4.3614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5870 4.6698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5858 3.5506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0544 3.8559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5244 5.2803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5257 6.3996 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0571 6.0943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3178 5.2555 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6500 2.9355 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1812 2.6271 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9937 5.5857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9943 4.4681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4624 4.7757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9301 6.2009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9296 7.3186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4615 7.0110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7889 0.0269 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0907 -2.3426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2582 6.9897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3038 8.4587 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
2 7 2 0
9 10 1 0
1 8 2 0
1 9 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
11 16 2 0
5 11 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
17 25 1 0
20 25 2 0
18 26 2 0
17 27 1 0
10 19 2 0
7 28 1 0
15 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 388.40Molecular Weight (Monoisotopic): 388.1336AlogP: 3.31#Rotatable Bonds: 3Polar Surface Area: 74.66Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.00CX Basic pKa: 3.79CX LogP: 3.18CX LogD: 3.18Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.70Np Likeness Score: -1.75
References 1. Deng CB, Li J, Li LY, Sun FJ.. (2016) Protective effect of novel substituted nicotine hydrazide analogues against hypoxic brain injury in neonatal rats via inhibition of caspase., 26 (13): [PMID:27216999 ] [10.1016/j.bmcl.2016.04.031 ]